Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia

Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.b15-00103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan